Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate + mefloquine for uncomplicated Plasmodium falciparum malaria in Vietnam
ACTRN12620001375943Phase 4Suspended
- Sponsor
- World Health Organization
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate and mefloquine in Malaria, sponsored by World Health Organization. Primary endpoints: Day 42 adequate clinical and parasitological response without and with PCR correction and Adverse events and safety. Started Oct 2019; status: suspended.
02
Drugs
artesunatemefloquine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12620001375943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620001375943.